Review
Open access
Sep 2026
Omentin-1 and cardiovascular disease: a comprehensive review from molecular mechanisms to clinical translation
Emerging evidence that commonly used cardiometabolic drugs can modulate omentin-1 levels is highlighted, supporting its potential as both a biomarker and a therapeutic target and highlighting recent advances in clinical research.
Ying-Cang Zhang, Wei Hao, Mei-Qi Luan et al.
· Frontiers in Endocrinology · 0 citations